Cemtrex (CETX) Responds to False, Misleading Blog Post on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
284
Cemtrex (CETX) Responds to False, Misleading Blog Post on Seeking Alpha

Farmingdale, NY, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Cemtrex, Inc. ( www.cemtrex.com , CETX)  today issued a response on behalf of its shareholders in relation to a malicious blog post containing false and misleading information published by short sellers on the Seeking Alpha website.

Cemtrex is preparing to take rapid legal action and asks that the SEC investigate these short sellers and their associates for stock manipulation and illicit gains. Cemtrex categorically refutes any allegations of wrong-doing by the Company, its directors, officers and management. In particular, Cemtrex would like to state the following:

Cemtrex has retained multiple auditors in various countries. Per the company’s most recent proxy statement dated January 30, 2017, approximately $95,000 of auditing fees were paid to multiple accounting firms including the Company’s PCOAB-approved accounting firm, Bharat Parikh & Associates, DHMP GmbH, and Stambaugh Ness.

As is easily confirmed by a review of Cemtrex’s proxy filings with the SEC, Aron Govil and Saagar Govil have not sold shares of Cemtrex in several years. In addition, CEO Saagar Govil and Cemtrex Founder Aron Govil are committed to purchasing additional shares of Cemtrex in the open market and will file the appropriate Form 4’s with the SEC accordingly in the days to come.

“We believe it is our responsibility to respond to this malicious article authored by a short seller with a clear motive to manipulate our share price and manufacture a false narrative about our company. Today’s blog post in Seeking Alpha amounts to nothing more than fake news created solely for the purpose of illicit gain by short sellers and we reject its contents entirely. The author has a history of writing rhetorical and damaging articles about companies where he holds a short position and we intend to pursue legal action against him and his cohorts immediately. Cemtrex has never misrepresented its investment proposition or financial performance to its shareholders and we stand by the contents of our SEC filings and press releases. Cemtrex urges the SEC to act quickly to address these malicious actions by the relevant short sellers and their associates. The author has conveniently failed to acknowledge all the tremendous accomplishments over the last three years.” stated Sagaar Govil, CEO of Cemtrex, Inc.

The Company also plans to hold it’s regularly schedule conference call tomorrow at 11AM ET. The details of which are:

Date: Thursday, February 23, 2017

Time: 11:00 AM Eastern Time (ET)

Dial-in Number for U.S. & Canadian Callers: 877-407-8293

Dial-in Number for International Callers (Outside of the U.S. & Canada): 201-689-8349

About Cemtrex

Cemtrex, Inc. (NASDAQ: CETX ) is a world leading diversified industrial and manufacturing company that provides a wide array of solutions to meet today's technology challenges. Cemtrex provides manufacturing services of advanced custom engineered electronics, industrial services, monitoring instruments for industrial processes and environmental compliance, and systems for controlling particulates, hazardous gases, emissions of Greenhouse gases, and other regulated pollutants used in emissions trading globally.

www.cemtrex.com

Safe Harbor Statement This press release contains forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date.  

Investor Relations Cemtrex, Inc. Phone: 631-756-9116 investors@cemtrex.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 3

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 2

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock's Strong Performance Lifts Market Spirits

Updated Category News Views 62

BlackRock's Earnings Impact Future Market Trends As investors eagerly glance at the market, recent trends suggest a positive shift, particularly with BlackRock, Inc. reporting remarkable third-quarter earnings. The upbeat results have lifted not only the company’s profile but also the sentiments across various sectors. Market Overview In recent trading sessions, U.S....

Continue Reading
Endo Unveils I Got Somebody Campaign for Peyronie's Disease

Updated Category News Views 648

Endo Launches Awareness Campaign for Peyronie’s Disease Endo, Inc. (OTCQX: NDOI) has recently introduced a compelling initiative titled I Got Somebody. This campaign is designed to encourage men to confront their feelings of embarrassment around Peyronie's disease (PD) and to have open discussions about this condition which affects many. The company aims to empower men...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
SeaStar Medical Advances adult AKI Treatment with Stanford

Updated Category News Views 69

SeaStar Medical Welcomes Stanford Medicine's Enrollment in AKI Trial SeaStar Medical Holding Corporation (NASDAQ: ICU) is excited to announce that Stanford Medicine will begin actively enrolling subjects in its pivotal trial focused on Adult Acute Kidney Injury (AKI). This collaboration emphasizes the company’s mission to enhance treatment options for patients...

Continue Reading
Exciting Updates on Class A Shares for Investors and Stakeholders

Updated Category News Views 163

Important Distribution Announcement for Class A Shareholders In a recent announcement, Real Estate Split Corp. (TSX: RS) has excitedly shared plans to distribute dividends to Class A shareholders. This distribution not only signifies growth but also represents the company's commitment to providing value to its investors. Key Dates for the Upcoming Distribution For...

Continue Reading